New 'Gene Silencer' Drug Reduces Cholesterol by Over 50 Percent

News   Mar 21, 2017 | Original story from Imperial College London

 
New 'Gene Silencer' Drug Reduces Cholesterol by Over 50 Percent
 
 
 

RELATED ARTICLES

Freedom of Information Request Reveals Benefits of Blocked MS Drug

News

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

READ MORE

Test Successfully Identifies Which Research Results in Mice Will Help Humans With MS

News

In determining which genes are conserved across species, the researchers also discovered a new gene that improves myelin repair.

READ MORE

New Version of CRISPR Corrects RNA Defects Linked to Huntington’s, ALS

News

Researchers have used CRISPR to correct the molecular mistakes that lead to microsatellite repeat expansion diseases, which include myotonic dystrophy types 1 and 2, the most common form of hereditary ALS, and Huntington's disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE